IMRX
Immuneering Corp
Next earnings ≈ Aug 14, 2026 · est. from filing cadence
Last earnings +0.4% on 2026-05-15
$4.79
▲ +4.13%$4.79▲ +72.92%
over 1Y
L $2.44EODHDH $9.26
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.1%
1W+4.3%
1M-12.7%
3M-13.5%
YTD-30.5%
1Y+66.1%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Conservative balance sheet (liabilities/equity 0.06x); but revenue fell -100.0% YoY.
Immuneering Corp shows $0.00 in FY2023 revenue (-100.0% YoY), and -25.6% ROE.
Sources: SEC EDGAR (CIK 0001790340, latest 10-Q filed 2026-05-15) · EODHD · as of 6/25/2026, 2:34:36 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.